Corrigendum to: “Gegen Qinlian decoction ameliorates murine colitis by inhibiting the expansion of Enterobacteriaceae through activating PPAR-γ signaling” Biomed. Pharmacother. 154 (2022) 113571

Corrigendum to: “Gegen Qinlian decoction ameliorates murine colitis by inhibiting the expansion of Enterobacteriaceae through activating PPAR-γ signaling” Biomed. Pharmacother. 154 (2022) 113571

Bibliographic Details
Main Authors:	Jingyi Hu, Yiheng Tong, Zhaofeng Shen, Yanan Li, Cheng Cheng, Ryan Au, Feng Xu, Yajun Liu, Lei Zhu, Hong Shen
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332222013841

Similar Items

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
by: Jing-Ze Lu, et al.
Published: (2021-05-01)

Network Pharmacology–Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction
by: Yu Xu, et al.
Published: (2021-07-01)

Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function
by: Xiaojun Wang, et al.
Published: (2023-06-01)

Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
by: Jun Tu, et al.
Published: (2020-06-01)

Gegen Qinlian decoction (GQD) inhibits ulcerative colitis by modulating ferroptosis-dependent pathway in mice and organoids
by: Xue Wang, et al.
Published: (2023-08-01)

Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral Gegen-Qinlian decoction in mice
by: Jing-Ze Lu, et al.
Published: (2022-10-01)

The potential effects and mechanisms of Gegen Qinlian Decoction in oxaliplatin-resistant colorectal cancer based on network pharmacology
by: Xiang Lin, et al.
Published: (2022-11-01)

Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids
by: Chang-Shun Liu, et al.
Published: (2019-04-01)

Metformin and Gegen Qinlian Decoction boost islet α-cell proliferation of the STZ induced diabetic rats
by: Li Xu, et al.
Published: (2022-07-01)

In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis
by: Xiaolu Liu, et al.
Published: (2021-06-01)

Gegen-Qinlian decoction alleviates anxiety-like behaviors in methamphetamine-withdrawn mice by regulating Akkermansia and metabolism in the colon
by: Xue Lu, et al.
Published: (2023-07-01)

Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury
by: Wei Li, et al.
Published: (2022-05-01)

Gegen Qinlian Decoction Ameliorates Hyperuricemia-Induced Renal Tubular Injury via Blocking the Inflammatory Signaling Pathway
by: Xiao-Jun Wang, et al.
Published: (2021-05-01)

Molecular mechanism of the effect of gegen qinlian decoction on type 2 diabetes mellitus based on network pharmacology and molecular docking
by: Shuai Zhao, et al.
Published: (2022-06-01)

Exploration of the Mechanism of the Control of Coccidiosis in Chickens Based on Network Pharmacology and Molecular Docking With the Addition of Modified Gegen Qinlian Decoction
by: Xiaomin Peng, et al.
Published: (2022-03-01)

Efficacy and safety of Gegen Qinlian decoction in the treatment of type II diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials
by: YiMei Tan, et al.
Published: (2024-01-01)

Gegen Qinlian Decoction Alleviates Experimental Colitis and Concurrent Lung Inflammation by Inhibiting the Recruitment of Inflammatory Myeloid Cells and Restoring Microbial Balance
by: Li Y, et al.
Published: (2022-02-01)

Corrigendum to “Tegaserod maleate exhibits antileukemic activity by targeting TRPM8” [Biomed. Pharmacother. 154 (2022) 113566]
by: Xiaoling Xie, et al.
Published: (2023-10-01)

Modified Gegen Qinlian Decoction Ameliorates DSS-Induced Ulcerative Colitis in Mice by Inhibiting Ferroptosis via Nrf2/GPX4 Pathway
by: Jinke Huang, et al.
Published: (2024-01-01)

A 42-Markers Pharmacokinetic Study Reveals Interactions of Berberine and Glycyrrhizic Acid in the Anti-diabetic Chinese Medicine Formula Gegen-Qinlian Decoction
by: Xue Qiao, et al.
Published: (2018-06-01)

Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota
by: Yifan Wang, et al.
Published: (2021-11-01)

Exploring the mechanism and key active components of Gegen Qinlian decoction combined with XELOX in the treatment of ulcerative colitis-associated colorectal cancer based on network pharmacology and multi-omics analysis
by: Qi Tang, et al.
Published: (2024-03-01)

Gegen Qinlian decoction restores the intestinal barrier in bacterial diarrhea piglets by promoting Lactobacillus growth and inhibiting the TLR2/MyD88/NF-κB pathway
by: Zhenye Luo, et al.
Published: (2022-11-01)

Gegen Qinlian standard decoction alleviated irinotecan-induced diarrhea via PI3K/AKT/NF-κB axis by network pharmacology prediction and experimental validation combination
by: Jiamei Chen, et al.
Published: (2023-04-01)

Corrigendum to “Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia” [Biomed. Pharmacother. 168 (2023) 115736]
by: Yuke Wang, et al.
Published: (2024-01-01)

Corrigendum to “Steatosis in metabolic diseases: A focus on lipolysis and lipophagy” [Biomed. Pharmacother. 160 (2023) 114311]
by: Xingtao Zhao, et al.
Published: (2023-07-01)

Corrigendum to “Paeonia lactiflora Pallas extract alleviates Antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice” [Biomed. Pharmacother. 154 (2022) 113574]
by: Seo Yeon Lee, et al.
Published: (2023-09-01)

Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01)

Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)

Retraction Notice to “Pharmacological evaluation of continentalic acid for antidiabetic potential” [Biomed. Pharmacother. 138 (2021) 111411]
by: Iqra Liaquat, et al.
Published: (2024-01-01)

Corrigendum to “Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering” [Biomed. Pharmacother. 148 (2022) 112782]
by: Murad Alahdal, et al.
Published: (2022-09-01)

Retraction notice to “Alkannin protects human renal proximal tubular epithelial cells from LPS-induced inflammatory injury by regulation of microRNA-210” [Biomed. Pharmacother. 108 (2018) 1679–1685]
by: Yiheng Chen, et al.
Published: (2022-06-01)

Corrigendum to “Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine” Biomed. Pharmacother. 170 (2024) 115952
by: Yu Chen, et al.
Published: (2024-01-01)

Corrigendum to “The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy” Biomed. Pharmacother. 165 (2023) 114893
by: Shuo Yuan, et al.
Published: (2024-02-01)

Corrigendum to “Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ” [Biomed. Pharmacother. 124 (2020) 109886]
by: Zhishen Xie, et al.
Published: (2023-12-01)

Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]
by: Lanqing Cao, et al.
Published: (2023-04-01)

The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury
by: Hu Fan, et al.
Published: (2012-12-01)

Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]
by: Chang Shin Yoon, et al.
Published: (2023-12-01)

Retraction notice to “Salidroside alleviates cigarette smoke-induced COPD in mice” [Biomed. Pharmacother. 86 (2017) 155–161]
by: Fen Luo, et al.
Published: (2023-04-01)

Network Pharmacology and Molecular Docking Analysis Reveal Insights into the Molecular Mechanism of Shengma-Gegen Decoction on Monkeypox
by: Liujiang Dai, et al.
Published: (2022-11-01)